The complexities of communicating results to #ComplexInnovativeDesign trial participants

National Institute for Health and Care Research

Το περιεχόμενο παρέχεται από το NIHR. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον NIHR ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.

4y ago 12:35

MP3•Αρχική οθόνη επεισοδίου

View the accessible transcript of this podcast
Professor Matt Sydes talks to Professor Allan Gaw about some of the challenges that researchers need to consider when communicating research findings to participants who have taken part in complex design trials such as a MAMS trial - multi-arm, multi-stage trial.
If a multi-arm platform trial answers more than one research question, should ALL participants hear about ALL the findings? Or just the arm they participated in? Matt draws on his experiences of the world-renowned STAMPEDE trial to offer some guidance.
This podcast is part of our 'Persectives from the Pandemic' series looking at the delivery of Complex and Innovative Design (CID) trials in the COVID-19 pandemic. You can access the full series of #ComplexInnovativeDesign trial podcasts on our website: www.nihr.ac.uk/documents/delivering-complex-and-innovative-trials-podcast-collection/29517

To find out more about how the NIHR supports complex and innovative design trials, visit: www.nihr.ac.uk/innovative-trials
You can listen to all our full collection of #ComplexInnovativeDesign trial podcasts on our website

53 επεισόδια

#Science #NIHR #Life Sciences #Research #Health and Well-Being #Funding